As of January 15, 2021, Levitas, Inc. closed the transaction. The company has received $1,011,644 in its second tranche. The company has received $19,011,644 in the transaction from five investors.
Thalys Medical Technology Group Corporation
Equities
603716
CNE1000030C3
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.34 CNY | -0.56% | +1.52% | -51.85% |
1st Jan change | Capi. | |
---|---|---|
-51.85% | 14Cr | |
-5.93% | 911.98Cr | |
+12.64% | 143.78Cr | |
-4.86% | 137.05Cr | |
-40.11% | 63Cr | |
-.--% | 62Cr | |
+8.52% | 48Cr | |
+1.58% | 43Cr | |
-38.14% | 27Cr | |
-65.61% | 24Cr |
- Stock Market
- Equities
- 603716 Stock
- News Thalys Medical Technology Group Corporation
- Levitas, Inc. announced that it has received $19.011644 million in funding from Thalys Medical Technology Group Inc., Decheng Capital LLC